Dr. Cauff is involved in clinical research in Pediatric Hematology/Oncology. He is an active member of the Children’s Oncology Group. The Children's Oncology Group (COG) is a worldwide research group supported by the National Cancer Institute (NCI) with the mission “to cure and prevent childhood and adolescent cancer through scientific discovery and compassionate care”. All of Dr. Cauff’s new oncology patients are entered into the Children’s Oncology Group registry and enrolled on clinical trials, if appropriate. In 2008, the Division of Pediatric Hematology/Oncology registered 17 patients on active COG treatment protocols and 49 patients on biology and banking protocols. There are 60 active COG treatment and biology studies open for patients at Joe DiMaggio Children’s Hospital.

Dr. Cauff oversees all policies, procedures and treatment plans to make sure that the research protocols are rigorously followed to insure the best outcomes. Data from his patients is used to develop standardized, evidence-based protocols for pediatric cancer patients. This data is also periodically published in national medical journals.

Dr. Cauff recently published a case report:

Cauff BE, Quinn CT; Transient parvovirus-associated hypoplasia of multiple peripheral blood cell lines in children with chronic hemolytic anemia. Pediatr Blood Cancer. 2008 Apr;50(4):861-4

Dr. Cauff participated in basic science research during his fellowship as well, focusing on homologous recombination in hematopoietic stem cells.